• 1
    Bewick M, Stewart PH, Rudge C, Farrand C, McColl I. Avascular necrosis of bone in patients undergoing renal allotransplantation. Clin Nephrol. 1976; 5: 6672.
  • 2
    Hawking KM. Avascular necrosis of bone after renal transplant [letter]. N Engl J Med. 1976; 294: 397.
  • 3
    Atkinson K, Cohen M, Biggs J. Avascular necrosis of the femoral head secondary to corticosteroid therapy for graft-versus-host disease after marrow transplantation: effective therapy with hip arthroplasty. Bone Marrow Transplant. 1987; 2: 421426.
  • 4
    Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg [Am]. 1995; 77: 459474.
  • 5
    Chang CC, Greenspan A, Gershwin ME. Osteonecrosis: current perspectives on pathogenesis and treatment. Semin Arthritis Rheum. 1993; 23: 4769.
  • 6
    Mankin HJ. Nontraumatic necrosis of bone (osteonecrosis) N Engl J Med. 1992; 326: 14731479.
  • 7
    Vreden SG, Hermus AR, van Liessum PA, Pieters GF, Smals AG, Kloppenborg PW. Aseptic bone necrosis in patients on glucocorticoid replacement therapy. Neth J Med. 1991; 39: 153157.
  • 8
    Sullivan KM. Graft versus host disease. In: FormanSJ, BlumeKG, ThomasED. Bone marrow transplantation. Boston: Blackwell Scientific, 1994: 339362.
  • 9
    Tauchmanovà L, Serio B, del Puente A,et al. Long-lasting bone damage detected by dual energy x-ray absorptiometry, phalangeal osteosonogrammetry and in vitro growth of marrow stromal cells after allogeneic stem cell transplantation. J Clin Endocrinol Metab. 2002; 87: 50585065.
  • 10
    Stulberg BN. Editorial comment on fifth international symposium on bone circulation. Clin Orthop. 1997; 334: 23.
  • 11
    Dumont M, Dunais S, Taillefer R. “Doughnut” sign in avascular necrosis of the bone. Clin Nucl Med. 1983; 9: 4447.
  • 12
    Enright H, Haake R, Weisdor D. Avascular necrosis of bone: a common serious complication of allogeneic bone marrow transplantation. Am J Med. 1990; 89: 733738.
  • 13
    Sociè G, Selimi G, Sedel L, et al. Avascular necrosis of bone after allogeneic bone marrow transplantation: clinical findings, incidence and risk factors. Br J Haematol. 1994; 86: 624628.
  • 14
    Sociè G, Cahn JY, Carmelo J, et al. Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors of 4388 patients by the Société Francaise de Greffe de Moëlle (SFGM). Br J Haematol. 1997; 97: 865870.
  • 15
    Fink JC, Leisenring WM, Sullivan KM, Sherrard DJ, Weiss NS. Avascular necrosis following bone marrow transplantation: a case-control study. Bone. 1998; 22: 6771.
  • 16
    Mascarin M, Giavitto M, Zanazzo GA, et al. Avascular necrosis of bone in children undergoing allogeneic bone marrow transplantation. Cancer. 1991; 68: 655659.
  • 17
    Wiesmann A, Pereira P, Bohm P, Faul C, Kanz L, Einsele H. Avascular necrosis of bone following allogeneic stem cell transplantation: MR screening and therapeutic options. Bone Marrow Transplant. 1998; 22: 565569.
  • 18
    Ebeling PR, Thomas DM, Erbans B, Hopper JL, Szer J, Grigg A. Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation. J Bone Miner Res. 1999; 14: 342350.
  • 19
    Mazières B. Osteonecrosis. In: KlippelJH, DieppePA. Rheumatology. London: Mosby, 1994: 47.147.10.
  • 20
    Calandriello B, Grassi G. Idiopathic osteonecrosis of the femoral head. Epidemiological and aetiological factors. Ital J Orthop Trauma. 1982; 8: 918.
  • 21
    Shane R, Rivas MDC, Silverberg SJ, et al. Osteoporosis after cardiac transplant. Am J Med. 1993; 94: 257264.
  • 22
    Lee AH, Mull RL, Keenan GF, et al. Osteoporosis and bone morbidity in cardiac transplant recipients. Am J Med. 1994; 86: 3541.
  • 23
    Braun WE, Richmond BJ, Protiva DA, Gifford RW, Straffon RA. The incidence and management of osteoporosis, gout, and avascular necrosis in recipients of renal allografts functioning more than 20 years (level 5A) treated with prednisone and azathioprine. Transpl Proc. 1999; 31: 13661369.
  • 24
    Grotz W, Breitffennnldt K, Cybulla M. Immunosuppression and skeletal disorders. Transplant Proc. 2001; 33: 992993.
  • 25
    Mori A, Hashino S, Kobayashi S, et al. Avascular necrosis in the femoral head secondary to bone marrow infarction in patient with graft-versus-host disease after unrelated bone marrow transplantation. Ann Hematol. 2001; 80: 238242.
  • 26
    Stern JM, Sullivan KM, Ott SM, et al. Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study. Biol Blood Marrow Transplant. 2001; 7: 257264.
  • 27
    Zizic TM, Marcoux C, Hungerford DS, Dansereau JV, Stevens MB. Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am J Med. 1985; 79: 596604.
  • 28
    Gosling DC, Sampson WFD, MadLeod M, Hanby AM, Slapek M. Susceptibiliy of the rabbit and the rat to steroid osteonecrosis: an experimental study. Transplantation. 1987; 43: 751753.
  • 29
    Sato K, Satomi S, Oguma S, et al. Relationship between aseptic necrosis of femoral head bone and immunosuppression therapy, especially CsA administration. Nippon Geka Gakkai Zasshi. 1993; 94: 832839.
  • 30
    Wagener P, Schulte D, Link H, Kirchner H, Stoll M, Polwoda H. Musculoskeletal manifestations in patients after bone marrow transplantation. Initial clinical rheumatologic observation. Z Rheumatol. 1991; 50: 199203.
  • 31
    Torii Y, Hasegawa Y, Kubo T, et al. Osteonecrosis of the femoral head after allogeneic bone marrow transplantation. Clin Orthop. 2001; 382: 124132.